[go: up one dir, main page]

BR9815378A - Sistema de fornecimento de droga transdérmico para agente analgésico antiinflamatório compreendendo sal de dietilamÈnio diclofenac e o método de fabricação do mesmo. - Google Patents

Sistema de fornecimento de droga transdérmico para agente analgésico antiinflamatório compreendendo sal de dietilamÈnio diclofenac e o método de fabricação do mesmo.

Info

Publication number
BR9815378A
BR9815378A BR9815378-1A BR9815378A BR9815378A BR 9815378 A BR9815378 A BR 9815378A BR 9815378 A BR9815378 A BR 9815378A BR 9815378 A BR9815378 A BR 9815378A
Authority
BR
Brazil
Prior art keywords
diclofenac
transdermal drug
analgesic agent
manufacturing
inflammatory analgesic
Prior art date
Application number
BR9815378-1A
Other languages
English (en)
Other versions
BR9815378B1 (pt
Inventor
Jin Deog Song
Original Assignee
Sam Yang Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sam Yang Co filed Critical Sam Yang Co
Publication of BR9815378A publication Critical patent/BR9815378A/pt
Publication of BR9815378B1 publication Critical patent/BR9815378B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

<B>SISTEMA DE FORNECIMENTO DE DROGA TRANSDéRMICO PARA AGENTE ANALGéSICO ANTIINFLAMATóRIO COMPREENDENDO SAL DE DIETILAMÈNIO DICLOFENAC, E O MéTODO DE FABRICAçãO DO MESMO<D> A invenção refere-se a um sistema de fornecimento de droga transdérmico para agente analgésico antiinflamatório compreendendo sal de dietilamónio diclofenac, onde uma película de forro (1), uma camada de matriz (2) contendo ingredientes ativos, um revestimento de liberação (3), que é retirado antes da aplicação sobre a pele, são laminados no mesmo. Mais particularmente, a presente invenção refere-se a um sistema de fornecimento de droga transdérmico para agente analgésico antiinflamatório compreendendo sal de dietilamónio diclofenac, onde a penetração e adesão transdérmica da placa ao corpo são aumentadas por meio de uma camada de matriz que compreende um sal de dietilamónio diclofenac como ingrediente ativo além de polímero acrílico como constituinte adesivo, agente tensoativo não iónico como intensificador de absorção, terpeno e meio auxiliar de dissolução, e os constituintes volátil e não volátil da composição são aplicados separadamente no mesmo para reduzir, de modo significativo, o tempo de fabricação do mesmo.
BRPI9815378-1A 1997-09-26 1998-09-25 sistema de fornecimento de droga transdérmico para agente analgésico antiinflamatório e método de fabricação do mesmo. BR9815378B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1019970049084A KR19990026792A (ko) 1997-09-26 1997-09-26 디클로페낙 디에틸암모늄염을 함유한 매트릭스형 패취제제
PCT/KR1998/000295 WO1999016434A1 (en) 1997-09-26 1998-09-25 A transdermal drug delivery system for anti-inflammatory analgesic agent comprising diclofenac diethylammonium salt, and the manufacturing method thereof

Publications (2)

Publication Number Publication Date
BR9815378A true BR9815378A (pt) 2000-11-21
BR9815378B1 BR9815378B1 (pt) 2010-05-18

Family

ID=19521757

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9815378-1A BR9815378B1 (pt) 1997-09-26 1998-09-25 sistema de fornecimento de droga transdérmico para agente analgésico antiinflamatório e método de fabricação do mesmo.

Country Status (12)

Country Link
US (1) US6723337B1 (pt)
EP (1) EP1030660B1 (pt)
JP (1) JP2001517696A (pt)
KR (2) KR19990026792A (pt)
CN (1) CN1180773C (pt)
AU (1) AU726448B2 (pt)
BR (1) BR9815378B1 (pt)
CA (1) CA2304784C (pt)
DE (1) DE69822327T2 (pt)
ES (1) ES2213916T3 (pt)
NZ (1) NZ503112A (pt)
WO (1) WO1999016434A1 (pt)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4627945B2 (ja) * 1999-07-15 2011-02-09 久光製薬株式会社 経皮吸収製剤
KR20010026619A (ko) * 1999-09-08 2001-04-06 김동회 벌레물린 부위 처치용 패취제제
JP4653893B2 (ja) * 2000-01-27 2011-03-16 純一 須藤 二層型経皮吸収製剤
KR20010077445A (ko) * 2000-02-02 2001-08-20 김윤 세라믹이 함유된 매트릭스형 패취제
ATE517614T1 (de) 2000-04-18 2011-08-15 Hisamitsu Pharmaceutical Co Pflaster enthaltend einen anti-inflammatorischen wirkstoff
US6455067B1 (en) * 2000-05-24 2002-09-24 Sang-A Pharmaceutical Co., Ltd. Transdermal patch for nonsteroidal antiinflammatory drug(s)
KR100363476B1 (ko) * 2000-06-27 2002-12-05 대신제약주식회사 디크로 페낙 또는 그의 염들을 함유한 경피투과용 경고제
DE10032537A1 (de) * 2000-07-05 2002-01-31 Labtec Gmbh Dermales System, enthaltend 2-(3-Benzophenyl)Propionsäure
TWI290464B (en) * 2000-09-01 2007-12-01 Novartis Consumer Health Sa Treatment of burns
DE10049225A1 (de) * 2000-09-28 2002-04-11 Labtec Gmbh Dermales System, enthaltend Diclofenac
MXPA03003957A (es) * 2000-11-06 2003-08-19 Samyang Corp Sistema de liberacion transdermica de farmacos, con propiedades mejoradas de adhesion y absorbencia de agua.
KR20020035398A (ko) * 2000-11-06 2002-05-11 김윤 수지(手指)용 진통 소염 경피투여제
DE60236084D1 (de) * 2001-05-31 2010-06-02 Hisamitsu Pharmaceutical Co Perkutan resorbierbare pflaster
US20040258739A1 (en) * 2001-09-04 2004-12-23 Rudy Susilo Plaster for the treatment of dysfunctions and disorders of nails
DE10256774A1 (de) * 2002-12-05 2004-06-24 Lts Lohmann Therapie-Systeme Ag Transmucosale und transdermale Arzneimittel mit verbesserter Wirkstoffresorption
WO2004103338A1 (en) * 2003-05-19 2004-12-02 Bioprogress Plc Adhesives and film modifying compositions
JP4344175B2 (ja) * 2003-06-13 2009-10-14 リンテック株式会社 マトリックス型経皮吸収製剤の製造方法
JP2005325165A (ja) * 2004-05-12 2005-11-24 Three M Innovative Properties Co 100℃以下の温度で溶融塗布可能なヨウ素含有ホットメルト粘着剤および該粘着剤を用いた医療用粘着シート製品
ATE471146T1 (de) 2004-10-21 2010-07-15 Durect Corp Transdermale verabreichungssysteme
US8252319B2 (en) 2004-10-21 2012-08-28 Durect Corporation Transdermal delivery system for sufentanil
CN1895242B (zh) * 2006-04-13 2011-08-31 沈阳药科大学 双氯芬酸盐的透皮贴剂及制备方法
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
JP5542436B2 (ja) 2006-07-25 2014-07-09 テックフィールズ バイオケム カンパニー リミテッド 非常に速い皮膚透過率を有するジクロフェナクの正荷電水溶性プロドラッグ
KR20100020008A (ko) * 2007-05-18 2010-02-19 티티아이 엘뷰 가부시키가이샤 생물학적 인터페이스를 통한 활성 성분의 방출을 개선한 경피 전달 장치
KR20210103586A (ko) * 2007-06-04 2021-08-23 테크필즈 인크 매우 높은 피부 및 막 침투율을 가지는 비스테로이드성 소염제(nsaia) 약물전구체 및 이들의 새로운 의약적 용도
BRPI0812368A2 (pt) * 2007-06-08 2015-02-03 Samyang Corp Sistemas de liberação de droga transdérmica do tipo matriz e respectivo método de preparação.
EP2055298A1 (en) * 2007-10-30 2009-05-06 Novartis AG Topical composition
US8445037B2 (en) * 2008-10-28 2013-05-21 A. M. Todd Company Volatile distillate by-product of mint oil that promotes absorption and/or bioavailability of compounds of bio-medical and nutritional interest
CA3213470A1 (en) 2008-12-04 2010-06-10 Chongxi Yu High penetration compositions and their applications
US9078863B2 (en) * 2009-11-13 2015-07-14 The Invention Science Fund I, Llc Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject
US8439896B2 (en) * 2009-11-13 2013-05-14 The Invention Science Fund I, Llc Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject
US8894630B2 (en) * 2009-11-13 2014-11-25 The Invention Science Fund I, Llc Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject
EP2455066B1 (en) * 2010-11-08 2018-10-17 EPITECH GROUP S.p.A. Pharmacological preparation for topical use containing N-palmitoyl-vanillamide
BR112013016998A2 (pt) * 2010-12-29 2016-10-25 Pharmafilm S R L emplastro medicamentoso para a permeação transdérmica melhorada de diclofenaco dietilamônio
EP2865377B1 (en) * 2012-06-20 2020-10-14 Hisamitsu Pharmaceutical Co., Inc. Percutaneous absorption promoter and skin patch comprising same
WO2014068600A1 (en) 2012-11-02 2014-05-08 Zydus Technologies Limited Stable transdermal pharmaceutical drug delivery system comprising diclofenac
JP6295949B2 (ja) 2013-02-28 2018-03-20 東レ株式会社 複合半透膜およびその製造方法
EP3096746B1 (en) 2014-01-22 2019-03-13 4P Therapeutics Abuse and misuse deterrent transdermal systems
CN105708823A (zh) * 2016-04-08 2016-06-29 中国药科大学 一种长效双氯芬酸类透皮贴剂及其制备工艺
JP6918543B2 (ja) * 2017-03-27 2021-08-11 株式会社アルビオン 皮膚外用剤または化粧料用組成物
US20180311928A1 (en) * 2017-04-27 2018-11-01 Tesa Se Adhesive tape for splicing of metal sheets used in high-tension, high temperature processes
WO2021201059A1 (ja) * 2020-03-30 2021-10-07 三生医薬株式会社 メントールを含有する組成物
WO2022224184A1 (en) * 2021-04-22 2022-10-27 Pike Therapeutics, Inc. Transdermal pharmaceutical formulations for the treatment of chronic pain

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT380166B (de) * 1981-02-16 1986-04-25 Ciba Geigy Ag Verfahren zur herstellung topisch applizierbarer pharmazeutischer praeparate, enthaltend salze von alkancarbonsaeuren
US4537776A (en) 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
JPS61280426A (ja) 1985-06-04 1986-12-11 Ikeda Mohandou:Kk 消炎鎮痛用貼付剤
CH666621A5 (de) * 1986-06-27 1988-08-15 Ciba Geigy Ag Topisch applizierbare pharmazeutische zusammensetzungen mit systemischer wirkung.
IT1223343B (it) * 1987-11-03 1990-09-19 Also Lab Sas Formulazioni farmaceutiche per somministrazione transdermica
US5641504A (en) * 1988-06-09 1997-06-24 Alza Corporation Skin permeation enhancer compositions using glycerol monolinoleate
DK0428352T3 (da) 1989-11-14 1995-12-27 Beta Pharm Co Antiinflammatoriske præparater til udvendig anvendelse
JP3046346B2 (ja) * 1990-03-12 2000-05-29 昭和電工株式会社 外用剤基剤又は補助剤とそれを含有する人又は動物の外用剤
JP2849937B2 (ja) * 1990-04-18 1999-01-27 日東電工株式会社 医療用貼付剤
CA2058975C (en) 1990-10-30 2000-06-06 Shuichi Kasai Antiinflammatory gel preparation
JPH04193826A (ja) 1990-11-27 1992-07-13 Shirogane Seiyaku Kk ジクロフェナクナトリウム含有の経皮吸収型消炎・鎮痛貼布剤
MX9202350A (es) 1991-05-20 1992-11-01 Alza Corp Composiciones de incrementador de penetracion a la piel que usan monolinoleato de glicerol.
JP3086290B2 (ja) * 1991-07-26 2000-09-11 エスエス製薬株式会社 ジクロフェナクナトリウム貼付剤
EP0581587A3 (en) * 1992-07-31 1995-05-17 Tanabe Seiyaku Co Base material for transdermal administration.
GB2273044B (en) * 1992-12-02 1997-04-09 Pacific Chem Co Ltd Medicinal patches for percutaneous administration
US5429590A (en) * 1992-12-01 1995-07-04 Nitto Denko Corporation Medical water-absorptive polymer and dressing for wound and medical bandage using the same
JP2523428B2 (ja) 1992-12-04 1996-08-07 エスエス製薬株式会社 消炎鎮痛ゲル製剤
EP0682942A4 (en) * 1993-01-21 1996-12-04 Yamanouchi Pharma Co Ltd NEW ABSORBABLE PERCUTANEOUS PREPARATION.
JP3526887B2 (ja) 1993-04-23 2004-05-17 帝國製薬株式会社 消炎鎮痛外用貼付剤
JPH07206710A (ja) * 1994-01-21 1995-08-08 Nitto Denko Corp 経皮投薬用テープ製剤

Also Published As

Publication number Publication date
AU9464798A (en) 1999-04-23
BR9815378B1 (pt) 2010-05-18
NZ503112A (en) 2002-02-01
US6723337B1 (en) 2004-04-20
DE69822327D1 (de) 2004-04-15
DE69822327T2 (de) 2005-03-17
WO1999016434A1 (en) 1999-04-08
CN1180773C (zh) 2004-12-22
HK1030161A1 (en) 2001-04-27
KR100305216B1 (ko) 2001-11-30
CA2304784A1 (en) 1999-04-08
JP2001517696A (ja) 2001-10-09
EP1030660A1 (en) 2000-08-30
KR19990029556A (ko) 1999-04-26
CN1271280A (zh) 2000-10-25
ES2213916T3 (es) 2004-09-01
CA2304784C (en) 2003-04-22
KR19990026792A (ko) 1999-04-15
EP1030660B1 (en) 2004-03-10
AU726448B2 (en) 2000-11-09

Similar Documents

Publication Publication Date Title
BR9815378A (pt) Sistema de fornecimento de droga transdérmico para agente analgésico antiinflamatório compreendendo sal de dietilamÈnio diclofenac e o método de fabricação do mesmo.
JP2655983B2 (ja) チロシナーゼ抑制活性を有する薬物の安定性を改善する方法、及び、皮膚美白用貼付剤
KR100212961B1 (ko) 경피투여시스템
RU2176499C2 (ru) Композиция для чрескожного введения стероидных лекарственных средств и содержащий ее препарат
NO962933L (no) Östradiol-penetrasjonsforsterker for transdermal administrering
EP0314528B1 (en) Article for the controlled release and delivery of substances to animal tissues
ES2152979T3 (es) Sistema terapeutico transdermal que contiene estradiol.
BRPI0416063A (pt) composição de administração de medicamento por via transdérmica, método de produzir a composição de administração de medicamento por via transdérmica e método de controle de fluxo de um medicmanto de uma composição de administração de medicamento dérmica
WO2004047820A1 (ja) 温感パップ剤
CA2499093A1 (en) Pharmaceutical composition for topical delivery of meloxicam comprising an amine or amine as penetration enhancer.
PT957900E (pt) Composicoes e metodos para aplicacao topica de agentes terapeuticos
CN1172430A (zh) 含雌二醇的药膏
AR021459A1 (es) PARCHE QUE CONTIENE ESTRADIOL PARA LA APLICACIoN PERCUTÁNEA DE HORMONAS.
PE20040548A1 (es) Lamina revestida de adhesivo para administracion dermica de un inhibidor selectivo de ciclooxigenasa-2
JP2002284701A (ja) ざ瘡の局所治療用パッチ
ES2197077T3 (es) Dispositivo transdermico que comprende farmacos anti-inflamatorios no esteroides incorporados en una matriz de un polimero acrilico adhesivo.
CO5640120A2 (es) Formulacion y metodods para el tratamiento de trombocitemia
NO20031211L (no) Plaster omfattende diclofenac
BR0109893A (pt) Preparação farmacêutica de lerisetron na forma de um sistema terapêutico transdêrmico, uso da preparação, uso da substância ativa lerisetron e método para administrar a substância ativa lerisetron a um paciente
BRPI0415725A (pt) formulação aspergìvel transdérmica, método para administrar um agente farmaceuticamente ativo e método para formar uma pelìcula farmaceuticamente ativa
KR20210065931A (ko) 함수계 첩부제
BR9506279A (pt) Composição para uso em um sistema de liberação de droga transdérmica sistema de liberação transdérmica processo de administração de estrogênio através da pele e uso de um sistema de liberação transdérmica
ES2626597T3 (es) Preparación endérmica que contiene piroxicam
WO2007112287A3 (en) Hme transdermal compositions containing testosterone
BRPI0621577A2 (pt) sistema terapêutico transdermal para substáncias voláteis e/ou termolábeis

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11N Dismissal: publication cancelled [chapter 11.14 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 18/05/2010, OBSERVADAS AS CONDICOES LEGAIS.

B25D Requested change of name of applicant approved

Owner name: SAMYANG CORPORATION (KR)

B25D Requested change of name of applicant approved

Owner name: SAMYANG HOLDINGS CORPORATION (KR)

B25A Requested transfer of rights approved

Owner name: SAMYANG BIOPHARMACEUTICALS CORPORATION (KR)

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 18.05.2020